The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL

Matthew H Forsberg1 Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA, [email protected]

Amritava Das2 Wisconsin Institute for Discovery, University of Wisconsin, Madison, WI, USA, [email protected];3 Morgridge Institute for Research, University of Wisconsin, Madison, WI, USA

Krishanu Saha2 Wisconsin Institute for Discovery, University of Wisconsin, Madison, WI, USA, [email protected];4 Department of Medical History & Bioethics, University of Wisconsin, Madison, WI, USA, [email protected];5 Department of Biomedical Engineering, University of Wisconsin, Madison, WI, USA, [email protected]Correspondence[email protected]

Christian M Capitini1 Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA, [email protected];6 Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI, USA, [email protected]Correspondence[email protected]